Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A
Withdrawn
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 4
2005-04-01
The purpose of the study is to compare the pharmacokinetic parameters of ReFacto and Advate,
using the chromogenetic substrate assay to measure plasma Factor VIII activity in plasma.
Efficacy and Safety Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients in Canada With Hemophilia A - A Continuation of Baxter Study 060101
Completed
Baxalta now part of Shire
Phase 2/Phase 3
2004-12-17
The purpose of this study is to evaluate whether rAHF-PFM is safe and effective in the
treatment of children with hemophilia A. The study is open to pediatric patients in Canada
who completed Baxter Study 060101.
Efficacy and Safety Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients in Canada With Hemophilia A - A Continuation of Baxter Study 060101
Completed
Baxalta US Inc.
Phase 2/Phase 3
2004-12-17
The purpose of this study is to evaluate whether rAHF-PFM is safe and effective in the
treatment of children with hemophilia A. The study is open to pediatric patients in Canada
who completed Baxter Study 060101.
The primary objective of this post-authorization safety surveillance is to measure the
incidence of adverse events that are at least possibly related to ADVATE use, in subjects
receiving ADVATE in routine clinical practice.
The primary objective of this post-authorization safety surveillance is to measure the
incidence of adverse events that are at least possibly related to ADVATE use, in subjects
receiving ADVATE in routine clinical practice.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.